Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

Abstract Background Cerebral oxygenation monitoring may reduce the risk of death and neurologic complications in extremely preterm infants, but no such effects have yet been demonstrated in preterm infants in sufficiently powered randomised clinical trials. The objective of the SafeBoosC III trial i...

Full description

Bibliographic Details
Main Authors: Mathias Lühr Hansen, Adelina Pellicer, Christian Gluud, Eugene Dempsey, Jonathan Mintzer, Simon Hyttel-Sørensen, Anne Marie Heuchan, Cornelia Hagmann, Ebru Ergenekon, Gabriel Dimitriou, Gerhard Pichler, Gunnar Naulaers, Guoqiang Cheng, Hercilia Guimarães, Jakub Tkaczyk, Karen B. Kreutzer, Monica Fumagalli, Olivier Claris, Petra Lemmers, Siv Fredly, Tomasz Szczapa, Topun Austin, Janus Christian Jakobsen, Gorm Greisen
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Trials
Subjects:
Randomised clinical trial
Preterm
Near infrared spectroscopy
Protocol
Online Access:https://doi.org/10.1186/s13063-019-3955-6

Internet

https://doi.org/10.1186/s13063-019-3955-6

Similar Items